EFFECT OF COMBINATION OF PPAR GAMMA AND ALPHA AGONISTS ON INSULIN SENSITIVITY
EFFECT OF COMBINATION OF PPAR GAMMA AND ALPHA AGONISTS ON INSULIN SENSITIVITY
批准号:
7374166
负责人:
jerrold Michael OLEFSKY
金额:
$1.58万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-04-01 至 2006-11-30
中文摘要
该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子项目和研究者(PI)可能从另一个NIH来源获得主要资金,因此可以在其他CRISP条目中表示。所列机构为中心,不一定是研究者所在机构。研究贝特类药物和噻唑烷二酮对2型糖尿病患者胰岛素敏感性和脂代谢的影响。协同效应的发现将在开发用于管理具有胰岛素抵抗和2型糖尿病的受试者的策略中具有相当重要的意义。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Study the effect of fibrate and thiazolidinedione on aspects of insulin sensitivity and lipid metabolism in subjects with type 2 diabetes mellitus. The discovery of a synergistic effect would be of considerable importance in the development of strategies for the management of subjects with insulin resistance and type 2 diabetes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Effects of Fractalkine on Beta Cell Function
-
批准号:9332367
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2014
-
负责人:jerrold Michael OLEFSKY
-
依托单位:
Effects of Fractalkine on Beta Cell Function
-
批准号:8813806
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2014
-
负责人:jerrold Michael OLEFSKY
-
依托单位:
Effects of Fractalkine on Beta Cell Function
-
批准号:9109627
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2014
-
负责人:jerrold Michael OLEFSKY
-
依托单位:
Role of Inflammation and Insulin Resistance in Mouse Models of Breast Cancer
-
批准号:8072501
-
项目类别:
-
资助金额:$25.97万
-
财政年份:2011
-
负责人:jerrold Michael OLEFSKY
-
依托单位:
Molecular Mechanisms of Inflammation, Steatosis and Hepatic Insulin Resistance
-
批准号:8053109
-
项目类别:
-
资助金额:$75.32万
-
财政年份:2010
-
负责人:jerrold Michael OLEFSKY
-
依托单位:
INSULIN RECEPTORS AND THE GLUCOSE TRANSPORT SYSTEM
-
批准号:8004368
-
项目类别:
-
资助金额:$9.37万
-
财政年份:2010
-
负责人:jerrold Michael OLEFSKY
-
依托单位:
Molecular Mechanisms of Inflammation, Steatosis and Hepatic Insulin Resistance
-
批准号:8152191
-
项目类别:
-
资助金额:$74.52万
-
财政年份:2010
-
负责人:jerrold Michael OLEFSKY
-
依托单位:
PROJECT 2 - METABOLIC CONTROL OF REPRODUCTION
-
批准号:7683482
-
项目类别:
-
资助金额:$39.43万
-
财政年份:2009
-
负责人:jerrold Michael OLEFSKY
-
依托单位:
Diabetes Endocrinology Research Center
-
批准号:7980520
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2009
-
负责人:jerrold Michael OLEFSKY
-
依托单位:
Aipocyte/Macrophage Crosstalk in the Etiology of Insulin Resistance.
-
批准号:8472481
-
项目类别:
-
资助金额:$40.77万
-
财政年份:2007
-
负责人:jerrold Michael OLEFSKY
-
依托单位:
Functional Char. of Pro-Inflammatory Pathways Influencing Insulin Influencing Ins
-
批准号:7249790
-
项目类别:
-
资助金额:$43.79万
-
财政年份:2007
-
负责人:jerrold Michael OLEFSKY
-
依托单位:
Aipocyte/Macrophage Crosstalk in the Etiology of Insulin Resistance.
-
批准号:8355974
-
项目类别:
-
资助金额:$41.98万
-
财政年份:2007
-
负责人:jerrold Michael OLEFSKY
-
依托单位:
Aipocyte/Macrophage Crosstalk in the Etiology of Insulin Resistance.
-
批准号:8665903
-
项目类别:
-
资助金额:$42.0万
-
财政年份:2007
-
负责人:jerrold Michael OLEFSKY
-
依托单位:
Aipocyte/Macrophage Crosstalk in the Etiology of Insulin Resistance.
-
批准号:9041573
-
项目类别:
-
资助金额:$42.0万
-
财政年份:2007
-
负责人:jerrold Michael OLEFSKY
-
依托单位:
EVALUATION OF UNUSUAL FORMS OF INSULIN RESISTANCE
-
批准号:7374125
-
项目类别:
-
资助金额:$0.16万
-
财政年份:2006
-
负责人:jerrold Michael OLEFSKY
-
依托单位:
PIOGLITAZONE THERAPY FOR INFLAMMATORY PATHWAY COMPONENT OF INSULIN RESISTANCE
-
批准号:7374165
-
项目类别:
-
资助金额:$14.93万
-
财政年份:2006
-
负责人:jerrold Michael OLEFSKY
-
依托单位:
Estrogen Effects in Insulin Target and Granulosa Cells
-
批准号:6805479
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2004
-
负责人:jerrold Michael OLEFSKY
-
依托单位:
Diabetes Endocrinology Research Center
-
批准号:7835656
-
项目类别:
-
资助金额:$140.28万
-
财政年份:2003
-
负责人:jerrold Michael OLEFSKY
-
依托单位:
Evaluation of Unusual Forms of Insulin Resistance
-
批准号:7045364
-
项目类别:
-
资助金额:$1.3万
-
财政年份:2003
-
负责人:jerrold Michael OLEFSKY
-
依托单位:
ADMINISTRATIVE CORE
-
批准号:8913140
-
项目类别:
-
资助金额:$23.16万
-
财政年份:2003
-
负责人:jerrold Michael OLEFSKY
-
依托单位: